163
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

ORCID Icon, , , , , , , , , , , , ORCID Icon, ORCID Icon, & show all
Pages 2752-2755 | Received 06 Feb 2020, Accepted 17 May 2020, Published online: 12 Jun 2020
 

Disclosure statement

GH obtained research grants and is a member of the advisory boards of Celgene and Jansen. AAvdL obtained research grants from Celgene, Roche and Alexion. AAvdL is a member of the advisory boards of Celgene and Novartis.

Additional information

Funding

This study was supported by an unrestricted grant from Celgene Corporation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.